Surmodics announces agreement with Genentech/Roche to combine proprietary drug delivery system with Lucentis (ranibizumab) for the treatment of wet macular degeneration.
Vascular endothelial growth factor is implicated to cause loss of vision in both diabetic retinopathy and macular degeneration. Review of how VEGF works and effect treatments for diabetic retinopathy and macular degeneration.